NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,166 | +22.6% | 2,495 | +21.4% | 0.02% | 0.0% |
| Q2 2023 | $207,379 | -25.7% | 2,055 | -33.2% | 0.02% | -35.1% |
| Q4 2022 | $278,999 | -5.7% | 3,075 | -21.1% | 0.04% | -17.8% |
| Q3 2022 | $296,000 | -14.2% | 3,895 | -4.7% | 0.04% | -11.8% |
| Q2 2022 | $345,000 | +3.9% | 4,086 | +7.9% | 0.05% | +18.6% |
| Q1 2022 | $332,000 | +15.3% | 3,788 | +15.0% | 0.04% | +13.2% |
| Q4 2021 | $288,000 | +77.8% | 3,295 | +65.5% | 0.04% | +65.2% |
| Q3 2021 | $162,000 | -19.8% | 1,991 | -10.4% | 0.02% | -8.0% |
| Q2 2021 | $202,000 | +197.1% | 2,222 | +176.0% | 0.02% | +127.3% |
| Q1 2021 | $68,000 | +4.6% | 805 | +16.7% | 0.01% | -21.4% |
| Q4 2020 | $65,000 | -99.9% | 690 | +20.6% | 0.01% | -53.3% |
| Q1 2020 | $47,160,000 | -7.5% | 572 | +9.6% | 0.03% | -3.2% |
| Q4 2019 | $51,008,000 | – | 522 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |